Avidity Biosciences, Inc.
Clinical trials sponsored by Avidity Biosciences, Inc., explained in plain language.
-
Major trial tests new IV drug for debilitating muscle disease
Disease control OngoingThis study is testing whether an intravenous drug called AOC 1001 can improve muscle function and control symptoms in adults with myotonic dystrophy type 1 (DM1). Participants receive either the drug or a placebo via infusion every 8 weeks for about a year. The main goal is to se…
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Four-Year trial tests potential new treatment for debilitating muscle disease
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of an investigational drug called del-desiran for adults with myotonic dystrophy type 1 (DM1), a genetic muscle-wasting disease. Participants who completed a previous related study will receive an intravenous infusion o…
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC